OmniAb (OABI) Intangibles (2021 - 2026)
OmniAb (OABI) reported Intangibles of $119.1 million for Q1 2026, down 11.65% year-over-year from $134.8 million in Q1 2025, and down 4.82% quarter-over-quarter from $125.1 million in Q4 2025.
OmniAb (OABI) Intangibles (2021 - 2026) Analysis & Trends
OmniAb (OABI) has 6 years of Intangibles data on file, last reported at $119.1 million in Q1 2026.
- Intangibles for Q1 2026 came in at $119.1 million, down 11.65% year-over-year; the trailing twelve-month figure through Mar 2026 was $119.1 million (down 11.65% YoY), and the FY2025 annual result was $125.1 million, down 9.35% from the prior year.
- Intangibles retreated to $119.1 million in Q1 2026 per OABI's latest filing, from $125.1 million in the prior quarter.
- Over five years, Intangibles peaked at $167.2 million in Q4 2022 and troughed at $119.1 million in Q1 2026.
- A 5-year average of $144.9 million and a median of $145.8 million in 2024 frame the typical range for Intangibles.
- The sharpest annual moves came in 2022 and 2026: Intangibles slipped 5.15% in 2022, then slipped 11.65% in 2026.
- A 5-year view of Intangibles shows it stood at $167.2 million in 2022, then fell by 7.04% to $155.5 million in 2023, then fell by 11.2% to $138.1 million in 2024, then slipped by 9.35% to $125.1 million in 2025, then decreased by 4.82% to $119.1 million in 2026.
- Business Quant data shows OABI's Intangibles at $119.1 million in Q1 2026, $125.1 million in Q4 2025, and $128.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4.41 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 30.30 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 418.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 7.73 Mn |
| 10 | OmniAb | 294.96 Mn | 252.00 Mn | 14.41 Mn | 119.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 119.12 Mn |
| Dec 31, 2025 | 125.15 Mn |
| Sep 30, 2025 | 128.38 Mn |
| Jun 30, 2025 | 131.61 Mn |
| Mar 31, 2025 | 134.83 Mn |
| Dec 31, 2024 | 138.06 Mn |
| Sep 30, 2024 | 144.12 Mn |
| Jun 30, 2024 | 147.51 Mn |
| Mar 31, 2024 | 152.06 Mn |
| Dec 31, 2023 | 155.47 Mn |
| Sep 30, 2023 | 158.77 Mn |
| Jun 30, 2023 | 161.92 Mn |
| Mar 31, 2023 | 164.36 Mn |
| Dec 31, 2022 | 167.24 Mn |
| Dec 31, 2021 | 176.32 Mn |